Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Southern Italy Cooperative Oncology Group (SICOG) is a prominent non-profit clinical research organization based in Italy, specializing in the development and management of multicenter oncology clinical trials. Founded in 1988, the group serves as a collaborative network for academic researchers and clinicians to investigate innovative treatment protocols and therapeutic combinations. SICOG's research portfolio spans a wide range of malignancies, with a particular emphasis on breast, lung, and gastrointestinal cancers. By coordinating Phase II and Phase III trials, the organization provides critical data that informs clinical practice and the integration of new pharmacological agents into standard care. SICOG maintains strong ties with both national and international oncology communities, contributing significantly to the advancement of evidence-based cancer therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southern Italy Cooperative Oncology Group.